Catalyst Wire Dossier Catalyst Wire Dossier

Dexmecamylamine (TC-5214)

dexmecamylamine · Targacept Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dexmecamylamine (TC-5214), covering 2015-06-03 to 2015-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder [Phase 2]

See pricing